NFKB1 and colorectal carcinoma: Overall, the data indicate that the inhibitory effect of AdoMet on P-gp expression and its ability to revert the 5-FU-induced chemoresistance of HCT 116p53+/+ and LoVo CRC cells were closely associated with the inhibition of NF-κB signaling activation.